Advancing HbA1c Testing: Introducing the MQ-3000 & MQ-8000

HORIBA is proud to expand its U.S. diagnostic portfolio through a strategic partnership with MEDCONN Diagnostics, introducing the MQ-3000 and MQ-8000 HbA1c Analyzers. These systems strengthen our commitment to delivering reliable, high-quality diabetes testing solutions for clinical laboratories.

Key Benefits

• Gold Standard HPLC Technology
• Reliable HbA1c testing performance
• Enhanced workflow efficiency
• Flexible solutions for laboratories of all sizes
• Expanded diabetes diagnostic capabilities

The MQ-3000 and MQ-8000 analyzers are expected to be commercially available in the United States in Summer 2026. Additional product information and resources will be available soon.